OPENING OF BANKRUPTCY

LIVELUNGER

Export PDF

Company — Opening of bankruptcy.

Financial year 2024 · Closed on 31/12/2024

Net result-92,6 k €
Gross margin-87,7 k €
Equity107,4 k €

Identity

Source · BCE/KBO

LIVELUNGER is a Private limited company incorporated in 2024. Its main activity is: Computer consultancy activities. Its registered office is in Gent.

Legal situation
Opening of bankruptcy
BCE/KBO no. / VAT
BE 1006.932.254
Incorporation
08/03/2024
Legal form
Private limited company
Registered office
Kliniekstraat 27 box a
9050 Gent · FlandreSee on map
Contributed capital
200 000,00 €
Latest accounts
31/12/2024
Signals
Solid equityGood liquidity

Financials

Source · NBB, 1 filing

Trend over 1 financial year

2024
Income statement
Gross margin-87,7 k €
EBITDA-87,7 k €
Operating result-92,3 k €
Net result-92,6 k €
Balance sheet
Equity107,4 k €
Total assets198,4 k €
Cash85,5 k €
Debts91 k €

Board of directors

Source · NBB, accounts to 31/12/2024

2 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Dupont Health Solutions0669.607.925Represented by Vincent DUPONT
Directorsince 08/03/2024
EFIKA SCIENCES0691.575.356Represented by Veerle DE COLVENAER
Directorsince 08/03/2024

Other companies at this address

Kliniekstraat 27 9050 Gent
CompanyCBE no.
GERBER TECHNOLOGY● Active
0407.029.024
Jofejen● Active
0701.973.360
Lectra Benelux● Active
0422.767.669
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA● Active
0628.646.310

Full financial information

Source · NBB
2024
Type of accountMicro model
Start of the financial year08/03/2024
Closing of the financial year31/12/2024
Length of the financial year10 months
Filing date07/07/2025
General meeting12/06/2025
Currency of the financial yearEUR
NBB quality labelSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 1 filing
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202412/06/202507/07/2025DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Dupont Health Solutions0669.607.925Represented by Vincent DUPONT
Directorsince 08/03/2024
EFIKA SCIENCES0691.575.356Represented by Veerle DE COLVENAER
Directorsince 08/03/2024

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates06/10/2025
    ONTSLAG BESTUURDER
    PDF
  • Mandates25/09/2025
    BENOEMING BESTUURDER
    PDF
  • Other07/07/2025
    Adreswijziging
    PDF
  • Other12/03/2024
    OPRICHTING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings1 filing
Mandates
Dupont Health Solutions
EFIKA SCIENCES
202420252026
LIVELUNGER
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Kliniekstraat 27 bte a, 9050 Ledeberg (Gent)Current
CBE
Kliniekstraat 27a, 9000 Gent
accounts 2024
Accounts 2024 · 2025-00236906

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
LIVELUNGERCurrent
accounts 2024
Accounts 2024 · 2025-00236906

Events

  1. 2024
    Annual accounts 2024-92,6 k €
  2. 08/03/2024
    IncorporationPrivate limited company